Innovative Healthcare Institute shared on LinkedIn:
“The treatment landscape for ALK– and ROS1-driven NSCLC continues to advance, making current knowledge of testing, treatment selection, resistance, and sequencing increasingly important.
Join David Mosko, MD, of St. Elizabeth Healthcare at the Best of Lung Cancer Conference for a focused update on the management of ALK and ROS1 aberrations.
October 3, 2026 | Cincinnati, Ohio
Register Today: Best of Lung Cancer
Hosted by Innovative Healthcare Institute, Abdul Rahman Jazieh, with support from OncoDaily, American Lung Association, Community Oncology Alliance (COA), and International Oncology Network Solutions, Inc. (ION).”
Other articles about lung cancer on OncoDaily.